Área Sanitaria de Ferrol
Área sanitaria
![Foto de Área Sanitaria de Ferrol](/img/noimage.png)
![Foto de Hospital Universitari Germans Trias i Pujol](/img/noimage_org.png)
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (72)
2024
-
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Diabetes care, Vol. 47, Núm. 2, pp. 216-224
-
Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus
Advances in Therapy, Vol. 41, Núm. 4, pp. 1372-1384
-
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort
Gastroenterologia y Hepatologia
-
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
British Journal of Surgery, Vol. 111, Núm. 1
-
Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study: Glucometrics knowledge and glycemic control in type 1 diabetes.
Diabetes and Metabolism
-
Laboratory Report of HIV-1 Low-Level Viremia
Open Forum Infectious Diseases
-
Nutritional and Morphofunctional Assessment of Post-ICU Patients with COVID-19 at Hospital Discharge: NutriEcoMuscle Study
Nutrients, Vol. 16, Núm. 6
-
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease
Gastroenterologia y Hepatologia
-
Response to Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224
Diabetes care, Vol. 47, Núm. 5, pp. e46-e47
-
Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry
Cirugia Espanola
2023
-
A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Open Forum Infectious Diseases, Vol. 10, Núm. 11
-
Changing trends in transgender demographics and morbidity: baseline data from a Spanish cohort
Sexual health, Vol. 20, Núm. 1, pp. 96-98
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes
Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336
-
Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881
-
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors
Frontiers in Immunology, Vol. 14
-
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1
Journal of Infectious Diseases
-
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204
-
Plasma Human Immunodeficiency Virus 1 RNA and CD4+T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes with Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study
Clinical Infectious Diseases